Home › Carcinoma a cellule squamose della testa e del collo › California › San Diego
Studi clinici su Carcinoma a cellule squamose della testa e del collo a San Diego, CA
14 studi su Carcinoma a cellule squamose della testa e del collo cercano partecipanti presso sedi a San Diego e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
In reclutamentoFase 1
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · a 11 mi di distanza
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
In reclutamentoFase 2/3
- Site #0107, La Jolla · a 11 mi di distanza
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
In reclutamentoFase 1
- ALX Center 9, La Jolla · a 11 mi di distanza
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
In reclutamentoFase 3
- Scripps Health, La Jolla · a 11 mi di distanza
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
In reclutamentoFase 3
- University of California at San Diego Moores Cancer Center, La Jolla · a 11 mi di distanza
Intratumoral N17350 in Advanced Solid Tumors
In reclutamentoFase 1/2
- Scripps Clinic Torrey Pines - La Jolla, San Diego
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
In reclutamentoStudio osservazionale
- University of California, San Diego, La Jolla · a 11 mi di distanza
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
In reclutamentoFase 1
- UC San Diego Moores Cancer Center, La Jolla · a 11 mi di distanza
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
In reclutamentoFase 2/3
- UC San Diego Medical Center - Hillcrest, San Diego
- UC San Diego Moores Cancer Center, La Jolla · a 11 mi di distanza
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck Cancer
In reclutamentoFase 2
- UC San Diego Medical Center - Hillcrest, San Diego
- UC San Diego Moores Cancer Center, La Jolla · a 11 mi di distanza
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
In reclutamentoFase 1/2
- Sharp Healthcare, San Diego
- UCSD, La Jolla · a 11 mi di distanza
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
In reclutamentoFase 1/2
- UCSD Moores Cancer Center, La Jolla · a 11 mi di distanza
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
In reclutamentoFase 1
- Moores Cancer Center UC San Diego Health, La Jolla · a 11 mi di distanza
A Beta-only IL-2 ImmunoTherapY Study
In reclutamentoFase 1/2
- Sharp Memorial Hospital, San Diego
Studi su Carcinoma a cellule squamose della testa e del collo in altre città
- Houston, TX47 studi
- Los Angeles, CA42 studi
- Boston, MA40 studi
- Nashville, TN39 studi
- New York City, NY39 studi
- St. Louis, MO28 studi
- Arlington, VA26 studi
- Chicago, IL26 studi
- Philadelphia, PA26 studi
- Atlanta, GA24 studi
- San Antonio, TX22 studi
- Pittsburgh, PA22 studi
Altri studi a San Diego
- Cancro del polmone non a piccole cellule48 studi
- Cancro al seno41 studi
- Cancro (tutti i tipi)32 studi
- Cancro alla prostata31 studi
- Cancro metastatico30 studi
- Cancro colorettale25 studi
- Cancro ovarico24 studi
- Cancro pancreatico24 studi
- Cancro ai polmoni23 studi
- Obesità23 studi
- Insufficienza cardiaca23 studi
- Depressione21 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.